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High density lipoprotein (HDL), the carrier of so-called “good”
cholesterol, serves as the major athero-protective lipoprotein and
has emerged as a key therapeutic target for cardiovascular
disease. We applied small angle neutron scattering (SANS)
with contrast variation and selective isotopic deuteration to
the study of nascent HDL to obtain the low resolution struc-
ture in solution of the overall time-averaged conformation of
apolipoprotein AI (apoA-I) versus the lipid (acyl chain) core
of the particle. Remarkably, apoA-I is observed to possess an
open helical shape that wraps around a central ellipsoidal
lipid phase. Using the low resolution SANS shapes of the pro-
tein and lipid core as scaffolding, an all-atom computational
model for the protein and lipid components of nascent HDL
was developed by integrating complementary structural data
from hydrogen/deuterium exchange mass spectrometry and
previously published constraints from multiple biophysical
techniques. Both SANS data and the new computational
model, the double superhelix model, suggest an unexpected
structural arrangement of protein and lipids of nascent HDL,
an anti-parallel double superhelix wrapped around an ellipsoi-
dal lipid phase. The protein and lipid organization in nascent
HDL envisages a potential generalized mechanism for lipopro-
tein biogenesis and remodeling, biological processes critical to
sterol and lipid transport, organismal energy metabolism, and
innate immunity.
High density lipoprotein (HDL)2 functions in removal of
cholesterol from peripheral tissues, such as within the artery
wall, for delivery to the liver and ultimate excretion as biliary
cholesterol within the intestinal lumen, a process called reverse
cholesterol transport (1, 2). Plasma levels of HDL cholesterol
and apolipoprotein AI (apoA-I), the major protein component
of HDL, are inversely related to the risk of developing coronary
artery disease (3–5). Moreover, genetic alterations that induce
changes in apoA-I levels in both animals and humans alter sus-
ceptibility for development of atherosclerotic heart disease
(3–6). Thus, numerous interventions aimed at enhancing
reverse cholesterol transport are being examined as potential
novel therapeutic interventions for the prevention and treat-
ment of cardiovascular disease (7, 8). Examples include meth-
ods for generating new HDL particles through enhanced pro-
duction or delivery of either intact apoA-I (9, 10) or peptide
mimetics of apoA-I (11), as well as modulating interactions
between nascent HDL and proteins involved in HDL particle
maturation and remodeling for potential therapeutic benefit
(12–14). Structural elucidation often serves as the “Rosetta
Stone” for enhanced understanding of function. It is thus
remarkable that despite its importance to numerous biological
and biomedical functions and its current prominent role as a
target for therapeutic interventions, to date, the structures of
neither the protein nor lipid components of nascent HDL have
been directly visualized, and the high resolution structure of the
particle remains unknown.
In the absence of high resolution structures, numerousmod-
els of nascent HDL have been proposed (recently reviewed in
Refs. 15, 16). In general, these have relied on various biophysical
and biochemical studies and are named after the proposed
overall architecture of apoA-I within the particle (e.g. picket
fence model (17), double belt model (18, 19), various hairpin
loop models (20–22), and most recently, the solar flares model
(23)). Each of thesemodels of nascent HDL assumes a structure
composed of a central phospholipid and cholesterol bilayer
with amphipathic-helical apoA-I arranged around the perim-
eter of the central lipid core. Refinement of the protein orien-
tation has been dictated by biophysically determined con-
straints such as hydrophobic/hydrophilic character along the
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predicted -helices, overall -helical content as estimated by
circular dichroism, measured distance constraints between
inter- and intra-chain amino acids bymultiple approaches, and
more recently, quantitative indices of solvent accessibility and
dynamics as determined by amide bond hydrogen/deuterium
exchange throughout the apoA-I polypeptide backbone. Al-
though all current models share an anti-parallel orientation of
two apoA-I predominantly -helical chains, the overall confor-
mation of the apoA-I -helical chains within the particle is still
debated. Of note, none of themodels is based upon studies that
provide direct imaging of the shape of apoA-I or the lipid core
within nascent HDL in solution.
Structural data from individual low resolution platforms can
have limited usefulness in resolving the molecular structure of
biological compounds, but limitations in structural definition
inherent in individual low resolution biophysical approaches
can be partially overcome by combining them synergistically
(24–26). Indeed, it is becoming increasingly recognized within
the structural biology field that merging multiple complemen-
tary techniques can prove particularly valuable when only low
resolution structures are available. For example, Fleishman et
al. (27) have recently shown how combining multiple biophys-
ical/biochemical constraints and computational analyses cou-
pled with cryo-EM low resolution data can result in enhanced
resolution, as well as provide mechanistic understanding of
membrane protein structure and function without crystallo-
graphic data.
Herein, we develop and apply to the study of nascent HDL a
broadly applicable, multidisciplinary methodological platform
for investigating the solution structure of macromolecular
complexes resistant to traditional structural approaches. By
uniting the diverse yet synergistic nonperturbing experimental
techniques of small angle neutron scattering (SANS) with con-
trast variation, isotopic deuteration of selected macromolecule
components, and hydrogen/deuterium exchange tandemmass
spectrometry (HD-MS/MS), we have been able to describe the
time-averaged conformation of protein and lipid components
of nascent HDL separately at low resolution and then to
enhance the resolution of these shapes by incorporating multi-
ple additional biophysical constraints to build a computational
model for the particle.
EXPERIMENTAL PROCEDURES
Preparation of Nascent HDL—The particle composition
selected for our studies, the methods for particle generation,
and the functional characterizations performed to demonstrate
a biologically active particle closely alignwith the currentHDL-
based therapeutic interventions being evaluated in the clinic
(28–30) and nascent HDL produced by macrophages (31).
Human apoA-I was isolated from plasma of healthy volun-
teers. Briefly, human HDL was isolated from a pool of fresh
plasma by ultracentrifugation adjusted with KBr to a density
range of 1.07–1.21 g/ml as described. Lipid-free human apoA-I
was prepared by delipidation of isolated human HDL using
methanol:ether:chloroform followed by ion exchange chroma-
tography (32). The purity of isolated human apoA-Iwas verified
by SDS-PAGE. Recombinant human apoA-I was generated in
Escherichia coli and isolated as described previously (33). To
prepare deuterated recombinant human apoA-I, the kanamy-
cin-resistant plasmid pET20b encoding His6-tagged human
apoA-I was transformed into E. coli BL21(DE3) cells. Kanamy-
cin resistance allows efficient selection and maintenance of the
expression construct under high cell density growth conditions
required in deuterated minimal media (34–36). Cells were
grown in 85% deuterated minimal medium (85% D2O), 15%
H2O, 6.86 g/liter (NH4)2SO4, 1.56 g/liter KH2PO4, 6.48 g/liter
Na2HPO42H2O, 0.49 g/liter diammonium hydrogen citrate,
0.25 g/liter MgSO47H2O, 1.0 ml/liter (0.5 g/liter CaCl22H2O,
16.7 g/liter FeCl36H2O, 0.18 g/liter ZnSO47H2O, 0.16 g/liter
CuSO45H2O, 0.15 g/liter MnSO44H2O, 0.18 g/liter
CoCl26H2O, 20.1 g/liter EDTA), 40 mg/liter kanamycin with
hydrogenated glycerol as carbon source (5 g/liter). Deuterated
apoA-I was purified by nickel affinity chromatography using
established methods (23, 33).
Reconstituted nascentHDLwas prepared using themodified
sodium cholate dialysis method (37) at an initial molar ratio of
100:10:1 of POPC:cholesterol:isolated apoA-I, which is a mod-
ification of the original seminal studies by Matz and Jonas (32)
who first reported the cholate dialysismethod for reconstituted
HDL preparation. HDL particles were further purified by gel
filtration chromatography using a Sephacryl S300 column (GE
Healthcare). The size of reconstituted nascent HDL was rou-
tinely measured as described previously using dynamic light
scattering and nondenaturing PAGE (23). The stoichiometry of
all nascentHDLpreparationswas determined as described pre-
viously (23). The amount of sodium cholate remaining in all
reconstituted nascentHDLpreparationswas quantified by high
pressure liquid chromatography tandem mass spectrometry
to confirm no significant residual cholate was present. The
stoichiometry of apoA-I on nascent HDL made of human
plasma isolated apoA-I (rHDL) and bacterially produced re-
combinant His-tagged apoA-I (rrHDL) were determined by
chemical cross-linking studies as described previously (23).
HDL Characterization by Circular Dichroism Spectroscopy—
Far-UV circular dichroism spectrawere recorded on an 815CD
spectrophotometer (Jasco). Reconstituted nascent HDL sam-
ples (rHDL and rrHDL) were analyzed at ambient temperature
in continuous scan mode with a 1-nm bandwidth at a wave-
length of 260 to 185 nm and with a path length of 1 mm. The
spectrawere normalized tomean residue ellipticitywith the use
of a mean residue molecular mass of 115.4 Da for apoA-I. Frac-
tional -helix contents were calculated using the neural net-
work-based K2d program (38).
HDL Characterized by Lecithin Cholesterol Acyltransferase
(LCAT) Activity Assay and LCAT Binding—The activation of
LCAT by rHDL and rrHDL with trace amounts of [3H]choles-
terol added was measured as described before with slight mod-
ification (23). The reaction complex contained 0–35 M cho-
lesterol in a final concentration of 10 mM phosphate (pH 7.4), 1
mM EDTA, 150 mMNaCl, 2 mM -mercaptoethanol, 0.6% fatty
acid-free bovine serum albumin, and 20 ng of purified His6-
tagged human LCAT (recombinant human LCAT). The reac-
tions were carried out in triplicate at 37 °C for 35 min under
argon. LCAT activity was determined by calculating the con-
version efficiency of [3H]cholesterol to [3H]cholesteryl ester
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after lipid extraction of reaction mixture followed by thin layer
chromatography (23).
Measurements of apparent dissociation constants between
LCAT and both rHDL and rrHDL were performed using a
BIAcore 3000 SPR Biosensor (BIAcore) following the methods of
Jin et al. (39) with modifications. Briefly, 8000 resonance
units of polyclonal antibody against apoA-I (Biodesign) was
immobilized on a CM5 sensor chip through primary amino
groups using reactive esters. Nascent HDLs were captured on
the sensor chip through interaction with antibody against
apoA-I by injecting 7 M HDL at a flow rate of 15 l/min in 10
mM PBS buffer (pH 7.4) into the flow cell. To determine the Kd
values between recombinant human LCAT and nascent HDL,
recombinant human LCATs ranging from 500 to 2000 nMwere
prepared in binding buffers of 10mM PBS (pH 7.4) and injected
over the surface of the sensor chip at a flow rate of 20l/min. At
the end of each cycle, surfaces of the sensor chips were regen-
erated by injection of 15 mM HCl at the same flow rate. The
apparent dissociation constants were obtained by fitting back-
ground-subtracted SPR binding data to the 1:1 binding with
drifting base-line model using the BIAevaluation software ver-
sion 4.0.
HDL Characterized by Cholesterol Efflux Assay—Subconflu-
ent J774A.1 murine macrophage cells in 48-well plates were
loaded by 0.3 Ci/ml [3H]cholesterol overnight in 0.4 ml of
DGGB (Dulbecco’s modified Eagle’s medium supplemented
with 50 mM glucose, 2 mM glutamine, and 0.2% bovine serum
albumin). The day after cholesterol was loaded, the cells were
washed three times in PBS and treated with or without various
5 g/ml HDLs for 6 h in serum-free Dulbecco’s modified
Eagle’s medium. The radioactivity in the chase media was
determined after brief centrifugation to remove pellet debris.
Radioactivity in the cells was determined by extraction in hexane:
isopropyl alcohol (3:2, v/v) with the solvent evaporated in a scin-
tillation vial prior to counting. The percent cholesterol efflux was
calculated by radioactivity in the medium divided by the total
radioactivity (medium radioactivity plus cell radioactivity) (33).
SR-BI-specific Binding of HDL—rHDL was iodinated using
Bolton-Hunter reagent to prevent oxidation of the particle (40).
293-T cells were transfected with vector or SR-BI using Lipo-
fectamine-2000 according to the manufacturer’s instructions.
The next day, cells were plated in 24-well plates, and after
another 24 h, specific binding of the radiolabeled rHDL to
SR-BIwas determined by incubating 125I-rHDLwith either vec-
tor-transfected or SR-BI-transfected cells for 1.5 h at 4 °C. After
1.5 h, cells were washed twice with 250 mM NaCl, 25 mM Tris
(pH 7.4) and once with 250mMNaCl, 25 mMTris (pH 7.4) with
2 mg/ml bovine serum albumin. Cells were solubilized in 1 ml
of 0.1 M NaOH at room temperature for 20 min, and cell-
associated radioactivity was subsequently determined with a
Gamma4000 spectrometer (Beckman Coulter, Fullerton, CA). Spe-
cific binding was calculated as total binding minus binding in
the presence of a 30-fold excess of unlabeled rHDL. For the
competition assay, a 30-fold excess of either unlabeled human
HDL from plasma, unlabeled reconstitutedHDL prepared with
recombinant apoA-I (rrHDL), or unlabeled POPC small unila-
mellar vesicles was added along with 100 g/ml iodinated
human HDL to determine inhibition of iodinated human HDL
binding to SR-BI (41).
Measurement of Anti-apoptotic Activity of HDL—Human
umbilical vein endothelial cells (HUVEC) were plated over-
night in 60-mmdishes inMCDBmedia supplementedwith 15%
fetal bovine serum. The next day, cells were washed with PBS,
and serum was deprived for 6 h with simultaneous incubation
with either 500 g/ml pHDL, 500 g/ml rHDL, 500 g/ml
apoA-I, or 500 g/ml small unilamellar vesicles generated with
POPC. After 6 h, apoptosis was measured using an annexin
V-fluorescein isothiocyanate apoptosis detection kit (Pharmin-
gen). Briefly, cells were washed twice with PBS, harvested, and
suspended in 1 binding buffer (10mMHepes/NaOH (pH 7.4),
140mMNaCl, 2.5 mMCaCl2) at a concentration of 106 cells/ml.
The solution was transferred to a 5-ml culture tube and incu-
bated with annexin and propidium iodide for 15 min at room
temperature in the dark according to the manufacturer’s
instructions. Flow cytometry of labeled cells was performed on
a FACScan (BD Biosciences).
Determination of Surface VCAM-1 Protein—HUVEC were
plated overnight in 96-well plates inMCDB-105 media supple-
mented with 15% fetal bovine serum. The next day, cells were
washed twice with PBS (pH 7.4) and preincubated with either
500 g/ml pHDL, 500 g/ml rHDL, 500 g/ml apoA-I, or 500
g/ml POPC small unilamellar vesicles for 2 h. After 2 h, 5
ng/ml of tumor necrosis factor- was added, and cells were
incubated for an additional 6 h. Cells were then washed three
times with PBS (pH 7.4) and fixed in 4% paraformaldehyde for
30 min on ice. Cells were subsequently washed and blocked
overnight with 5% bovine serum albumin. The day after
blocking, cells were incubated with anti-VCAM-1 primary
antibody (sc-53778, Santa Cruz Biotechnology) for 2 h at
room temperature. After three washes with PBS (pH 7.4), cells
were incubatedwith sheep anti-mouse horseradish peroxidase-
conjugated secondary antibody (GEHealthcare) for 2 h at room
temperature. 3,3,5,5-Tetramethylbenzidine substrate was sub-
sequently added to each well and the reaction stopped after 20
min by addition of 1 M HCl. Absorbance was recorded at 450
nm on a 96-well plate reader (Spectramax 384 Plus, Molecular
Devices, Sunnyvale, CA).
SANS Experiment—Small angle neutron scattering experi-
ments were carried out at the instrument D22 of the Institut
Laue-Langevin, Grenoble, France. D22 is a classical pinhole
camera that provides the highest neutron flux among all com-
parable SANS instruments in existence (42). Data collected
from twopositions of the detector (2 and 5.6mwith collimation
lengths of 2.8 and 5.6 m) covered the momentum transfer (q)
range from0.008 to 0.35Å1.q is defined as 2 (sin)/, where 2
is the scatteringangle.Thewavelengthof theneutronbeamused
was 6 Å. Data beyond 0.25 Å1 were too noisy to analyze.
To understand the organization of the protein and lipid in
HDL contrast variation ([D2O]/[H2O  D2O] ratio) was
required. The HDL samples were measured in 0, 12, 42, and
90% D2O solution to ensure the required levels of contrast.
From the corresponding scattering curves, two important
parameters were obtained for each contrast as follows: the
radius of gyration (Rg) and the intensity at 0 angle I(q  0). Rg
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values were obtained based on the Guinier approximation (43),
which is valid for q values (Rgq)21 (Equation 1).
limq3 0Icorrq	 I0	expRR
2q2/3	 (Eq. 1)
The logarithmic intensities varied linearly with q2 in the chosen
Guinier range and the obtained Rg were stable against slight
change in q range. Themolecular mass (M) of the HDL particle
was calculated as 200,000 Da based on the absolute scale mea-
sured I(q 0) (Equation 2), in whichC (mg/cm3) is the concen-
tration of HDL, b (cm) is the particle scattering length, V
(cm3) is the particle volume, 0 (cm2) is the solvent scattering
length density, and NA is Avogadro’s number; the term in
brackets is the particle excess scattering length normalized to
unit molecular mass (44). The molecular mass calculated from
the data corresponded to one HDL particle.
I0	/C  NAb	 p0V	/M	2M (Eq. 2)
The program DAMMIN (45), a simulated annealing method,
was used to calculate a low resolution model of the lipid core
from the scattering curve of the sample in 42% D2O. Likewise,
the 12% scattering curve was used for the modeling of the pro-
tein. In the approach, the starting structure is a sphere of diam-
eter equal to the maximum particle dimension, which was esti-
mated from the scattering curve, via the distance distribution
function P(r). The sphere was filled with dummy atoms with
their size determined by the highest value of momentum trans-
fer (q) of the scattering curve. To enhance the signal to noise
ratio of the sample in 12% D2O, deuterated apoA-I was used for
the reconstitution of the HDL particle. The 
 value of the simu-
lated annealing modeling for lipid is less than 1 and 5.2 for the
protein. Both are in the excellent or reasonable range of statistics.
SAXS Experiment—Small angle x-ray scattering data of nas-
cent HDL in solution were collected at the X33 beamline
(DESY, Hamburg, Germany) at particle concentrations ranging
from 2 to 16.0 mg/ml. At a sample detector distance of 2.7 m,
the range of momentum transfer 0.01 q 0.5 Å1 was cov-
ered (  0.15 nm the x-ray wavelength). The data were pro-
cessed with program PRIMUS (46) using standard procedures.
The forward scattering intensity I(q 0) and the radius of gyra-
tion (Rg) were evaluated with programAUTORG (47) using the
Guinier approximation. The effective molecular mass of the
solute was estimated by comparison of the forward scattering
intensity with that from reference solutions of bovine serum
albumin (molecular mass 66 kDa).
Electron Microscopy Studies—Negatively stained HDL was
obtained by applying a diluted solution of HDL particles (0.2
mg of protein/ml) to the clear side of carbon on a carbon-mica
interface and stained with 2% (w/v) uranyl acetate. Images were
recorded under low dose conditions with a JEOL 1200 EX II
microscope at 100 kV. Selected negativeswere then digitized on
a Zeiss scanner (Photoscan TD) at a step size of 14 m giving a
pixel size of 3.5 Å at the specimen level. Subsequent data pro-
cessing was performed with the Imagic package. The data set,
centered by translation, was subjected tomultivariate statistical
analysis and classification.
Computational Modeling of Nascent HDL—An all-atom
computationalmodel of nascentHDLwas constructed by com-
bining modeling techniques with experimental data, including
contrast variation SANS, HD-MS/MS data, and reported dis-
tance constraints from cross-linking, fluorescence resonance
energy transfer, and electron spin resonance experiments (20,
21, 48, 49). The overall strategy in constructing a model of nas-
cent HDL was to use the SANS low resolution structures
obtained by deconvoluting the experimental SANS curves of 12
and 42% D2O as scaffolds to build molecular models for the
protein and lipid components of nascent HDL, respectively.
The overallmodel building involved over 250 iterative steps (i.e.
over 250 models created for nascent HDL) with assessments of
the goodness of fit with both SANS curves and experimentally
determined H/D exchange data at every step. At each refine-
ment step, precedence was always placed on SANS data for
global conformation, whereas more fine-tuned refinements of
local architecture primarily utilized H/D exchange data. It is
worth noting that hydrogen/deuterium exchange, in conjunc-
tion with NMR and/or tandemmass spectrometry analysis (50,
51), has been used extensively in the past to determine the local
environment, such as solvent accessibility and dynamics, of
amino acid residues in proteins or in macromolecular com-
plexes involving proteins. Determination of H/D exchange
through either NMR or mass spectrometry methodology pro-
vides constraints that can help aide in structural modeling
because amide hydrogen H/D exchange rates (and their degree
of protection) are sensitive to the local environment of amino
acid residues in various protein secondary structures (-helix,
-pleated sheets, etc.). The degree of H/D exchange in amide
backbone hydrogen atoms depends upon both solvent accessibil-
ity and local interactions (e.g. participation in hydrogen bonds in
-helical sites, hydrophobic contacts, and protein dynamics).
An iterative co-refinement process was performed for each
contrast variation study to first develop an overall model of the
protein component based upon SANS and HD-MS/MS data,
then the lipid core, followed by a combined model with energy
minimization at every step. A startingmodel for the lipoprotein
was constructed using MODELER, PyMOL, and Swiss-PDB-
Viewer programs (52, 53), by arranging the apoA-I chains into
an anti-parallel superhelical conformation to match the 12%
D2O SANS low resolution structure. The crude protein model
obtained in this way was further refined by iteratively adjusting
the shape and the degree of protection of amide hydrogen for
exchange. As described in detail in the supplemental material,
the programDEXANAL (23)was used to determine per residue
deuterium incorporation factors (D0i), residue unfolding con-
stants (Kui), and H/D exchange rate constants (kxci) from the
experimental H/D exchange data of overlapping peptic pep-
tides. DEXANAL was also employed to calculate per residue
H/D exchange probabilities (XPi) from three-dimensional
molecular models. In this manner, an iterative co-refinement
approachwas used to improve the computationalmodel so that
predicted SANS andH/D exchange datamatched experimental
SANS andHD-MS/MS data. Use of DEXANAL for incorporat-
ing H/D exchange data into molecular models was validated
using proteins with known crystallographic structure and pub-
lished H/D exchange data as outlined in detail in supplemental
Figs. S1 and S2 and Tables S1–S4.
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Theneutron scattering curves of themodels of apoA-Iwithin
nascent HDL were computed using a modification of the
SASSIM program (54). Instrument smearing was taken into
account in calculating the scattering intensity as described in
Merzel and Smith (54), and the relative wavelength spread of
neutrons (
/)usedwas0.1as suggestedbySvergunetal. (55).At
each refinement step, the model was energy-minimized using the
OPLS force field (56) (using the GROMACS program (57)).
The lipid phase (200 POPC molecules and 20 cholesterol
molecules)wasmodeled to follow the helical orientation of pro-
tein hydrophobic surface filling the inside groove, and overall
fits the experimentally visualized SANS prolate ellipsoid
obtained by deconvoluting the 42% D2O scattering curve. The
lipid model was refined further by performing energy minimi-
zation of the whole particle and bymatching its calculated scat-
tering intensity curve to the experimentally obtained one (42%
D2O). Additional model refinement using experimental geo-
metrical constraints such as chemical cross-links, fluorescence
resonance energy transfer, and elec-
tron spin resonance distances are
described in detail in the supple-
mental material.
RESULTS
Small Angle Neutron Scattering of
Nascent HDL—Small angle scatter-
ing is a powerful approach for struc-
tural studies of macromolecules in
solution. It provides a low resolu-
tion structure and is particularly
useful in revealing details of the
organization of a multicomponent
system. For example, in a contrast
variation experiment of SANS,
D2O/H2O levels are varied such that
the scattering length density of the
solvent is adjusted tomatch that of a
component within a complex (e.g.
protein, lipid,DNA, orRNA), essen-
tially rendering that component
invisible (58). Thus, SANS can link
structural and compositional infor-
mation in solution in a way that is
difficult to attain by other
approaches. Indeed, SANS with
contrast variation was the first
method to correctly predict the
structural orientation of protein
and DNA within the fundamental
subunit of chromatin, the nucleo-
some (59), as well as to triangulate
the location of various proteins and
RNA within the ribosome (60–62),
the intracellular complex that trans-
lates the genetic code into proteins.
To probe the structure of apoA-I
within nascent HDL particles, we ex-
amined reconstituted nascent HDL
particlesproducedusinghumanapoA-I as describedunder “Exper-
imental Procedures.” Dynamic light scattering, biochemical,
and cross-linking/mass spectrometry analyses of HDL indi-
cated monodispersed preparations with two apoA-I molecules
per particle, and overall stoichiometry of apoA-I:phospholipid:
cholesterol of 1:100:10 (mol/mol; see Fig. 1). Prepared nas-
cent HDL particles for structural studies were confirmed to be
biologically functional with respect to a broad array of reported
HDL activities, including cholesterol efflux from cholesterol-
loadedmacrophages, LCAT binding, activity, and catalytic effi-
ciency, specific binding to the HDL receptor SR-BI, anti-apo-
ptotic activity, and anti-inflammatory activity (Figs. 2 and 3).
Absolute scale SANS analysis confirmed the predominance of a
200,000-Da lipoprotein particle in solution corresponding to
the monomer of nascent HDL containing two apoA-I per par-
ticle. To obtain information about the shape of apoA-I within
HDL, scattering intensity data were collected in 12% D2O. At
this concentration of D2O, the scattering length density of sol-
FIGURE 1.Characterizationof reconstitutednascentHDLparticles.NascentHDLparticleswerepreparedusing
amodified cholate dialysis method at amolar ratio of 100:10:1, POPC:cholesterol:apoA-I (76). Before being used in
structural analyses, HDL particles were characterized by a variety of biological, biochemical, and biophysicalmeth-
ods. A, nondenaturing gel analyses of reconstituted nascent HDL containing purified human apoA-I from healthy
donors (rHDL, left panel) and reconstitutednascentHDLcontaining recombinanthumanapoA-I purified fromE. coli
(rrHDL, rightpanel). PurifiednascentHDLbygel filtration (10gofprotein)was loadedona4–20%gradientgel. The
purity of the nascent HDL preparation was confirmed by ND-PAGE analysis. B, SDS-polyacrylamide gel analyses of
cross-linked apoA-I within rHDL and rrHDL particles. After cross-linking, a broad band was shown at about the
50–70-kDa position, indicating each HDL particle contains two apoA-I molecules. The broadened band pattern is
consistent with prior reports for an apoA-I dimer in similarly cross-linked HDL (20, 37). C, stoichiometry of reconsti-
tutedHDL.Thechemical compositionofHDLparticleswasdeterminedusingavarietyofmethods.D, sizeofnascent
HDLparticleswas determined both by comparisonwith the knowndiameter of globular standard proteins and by
light scattering spectroscopy (23). The results represent an average S.D. of threemeasurements.
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vent matches the average scattering length density of the lipid
phase masking it at low angle. However, the initial low resolu-
tion structure of apoA-I obtained by analysis of the scattering
curve at 12%D2Owas inconclusive (i.e.not useful for determin-
ing the overall shape of the protein), presumably because of the
weak signal intensity from protein at this D2O level and the
superposition of the residual signals produced by lipid polar
head group scattering at higher angles. To overcome the issue
of superimposed signals, we generated recombinant deuterated
apoA-I (by growing E. coli in D2O with deuterated nutrients)
for use in forming reconstituted nascent HDL. Because of the
difference in the scattering length of hydrogen and deuterium
(58), the deuterated apoA-I gives a
much stronger signal in 12% D2O
solvent.
Physical and biological proper-
ties of nascent HDL formed using
recombinant deuterated apoA-I
again demonstrated a biologically
active particle with the composi-
tional and functional characteristics
indistinguishable with reconstituted
HDL particle preparations generated
with apoA-I isolated from human
plasma. The experimental scatter-
ing intensity data from deuterated
apoA-I within nascent HDL in 12%
D2O (Fig. 4A) allowed direct visual-
ization of the overall time-averaged
conformation of apoA-I following
the simulated annealing method for
ab initio structure determination
(45). Unexpectedly, this low resolu-
tion SANS shape turned out to have
an open helical conformation (Fig.
4,B andC). Othermeasured param-
eters for the apoA-I component of
HDL include a radius of gyration
(Rg) of 51 Å, and the longest dimen-
sion (Dmax) of the protein to be
170 Å (Table 1).
SANS Analyses of Nascent HDL
Readily Discriminate among HDL
Models—Becausehydrogen anddeu-
terium have markedly different
neutron scattering properties, we
have used amodified program to pre-
dict the scattering curve for all-atom
structures of nonsphericalmacromo-
lecular targets (supplemental mate-
rial) (54). Visual inspection of the cal-
culated theoretical scattering curves
of more prominent models of
HDL, the belt (18, 19) and solar
flares models (23), reveals signifi-
cant deviations between the pre-
dicted and experimental SANS
curves (Fig. 4A). Both the belt and
solar flares models deviate from the experimental SANS data
at lower scattering angles and generate oscillatory scattering
curves with minima and maxima characteristic of a ring
shape at larger scattering angles. In additional investiga-
tions, we evaluated the scattering behavior of alternative
proposed shapes for apoA-I in nascent HDL, such as saddles
of differing curvature (supplemental Fig. S3) (63) or protein
shapes with hairpin loop conformation for what historically
is termed helix 5 (supplemental Fig. S4) (21). Again, because
of the closed symmetrical shape of apoA-I in these models,
the scattering curve demonstrates marked variation from
that observed experimentally, including oscillatory behavior
FIGURE 2. Cholesterol efflux and LCAT activity of nascent HDL. A, cholesterol efflux activity of human
plasma isolated HDL (pHDL), reconstituted nascent HDL containing purified human apoA-I from healthy
donors (rHDL), and reconstituted nascent HDL containing recombinant human apoA-I purified from E. coli
(rrHDL) were measured by incubating different HDLs with subconfluent J774A.1 murine macrophage cells
loaded with [3H]cholesterol. The cholesterol efflux was calculated by radioactivity in the medium divided by
the total radioactivity (medium radioactivity plus cell radioactivity) as described under “Experimental Proce-
dures.” Note that all three different HDLs have similar cholesterol efflux activity. B, rrHDL activates LCAT simi-
larly as rHDL. LCAT activity was measured as described under “Experimental Procedures.” Note that rrHDL
retains at least 85% of LCAT activation capacity compared with rHDL. C, dissociation constants of nascent
HDLLCAT complex determinedby surface plasmon resonance spectroscopy. The Kd value of binding between
the indicated HDL and recombinant human LCAT was determined as described under “Experimental Proce-
dures.” Note that rHDL and rrHDL demonstrate a similar affinity with LCAT. D, Hanes and Woolf (S/V versus S)
plot. The kinetic parameters of LCAT activity on rrHDL are similar to what is reported in the literature (Km, Vmax,
and kcat) (77, 78). All experimental results represent mean S.D. of three independent experiments.
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similar to the belt and solar flares models. SANS analyses
indicate that closed symmetrical protein structures such as
proposed in the belt, solar flares, and other ring models do
not accurately represent the shape of apoA-I within recom-
binant nascent HDL, but rather they reveal that an open
helical conformation for apoA-I is fully supported by the
SANS data.
Double Superhelix Model for ApoA-I within Nascent HDL—
Although SANS is a powerful approach for defining overall
shape at low resolution, it is insensitive to local conformation at
the level of amino acids and small peptides. In contrast, HD-
MS/MSprovides structural and dynamic information about the
local environment of the amide protons throughout the
polypeptide backbone at the amino acid or short peptide level
of resolution but is relatively insensitive to global particle shape.
Hydrogen/deuterium exchange data can provide structural
constraints for protein architecture and dynamics in solution,
and it is frequently used in NMR-based structural studies for
the study of the local environment of amino acid residues in
various protein secondary structures (helix, pleated sheets,
etc.). H/D exchange of amide backbone hydrogen atoms is
influenced by both solvent accessibility and protein dynamics,
which reflect specific local interactions such as participation in
hydrogen bonds within -helices, hydrophobic contacts, etc.
(25).
We therefore sought to integrate for the first time structural
information from both contrast variation SANS and HD-MS/MS
to extend the low resolution SANS structures for HDL through
development of computationalmodels that accommodate both
the overall global shape dictated by SANS and the constraints
imposed by measured hydrogen/deuterium exchange data for
apoA-I within nascent HDL. Thus, a new model of apoA-I was
built utilizing the low resolution SANS structure of HDL pro-
tein (Fig. 4B, left, and supplemental Fig. S5) as scaffold for the
construction of an initial computational model of apoA-I. The
startingmodel was energy-minimized and refined through iter-
ative calculations of SANS intensity and H/D exchange incor-
poration factors (supplemental Figs. S5 and S6 and Table S5).
Subsequently, additional geometrical constraints (experimen-
tally determined cross-linking/mass spectrometry, fluores-
cence resonance energy transfer, and electron spin resonance
coupling distance constraints (20, 21, 48)) were used to further
refine the overall shape of the protein within the computational
model. Clashes between atoms produced duringmodelingwere
removed by performing energy minimization at each step.
Next, a model of the lipid phase of HDL was constructed based
upon the experimental SANS structure of the lipid core (sup-
plemental Fig. S7) and the model of apoA-I within HDL. The
computational model developed for the solution structure for
nascent HDL (called the double superhelix model because of
the superhelical structure of the anti-parallel -helical apoA-I
chains) was thus obtained by combining all experimental data
(SANS,HD-MS/MS, cross-linking/mass spectrometry, fluores-
cence resonance energy transfer, and electron spin resonance
coupling) with integrative computational modeling tools (see
supplemental material).
The predicted structure of apoA-I within the double super-
helix model of nascent HDL is shown in Fig. 4B (right). Fig. 4A
shows the calculated scattering intensity of the double super-
helix model (blue line), which fits very well the experimental
scattering intensity curve. As in the previous belt and solar
flares models, the protein in the double superhelix model has
the two apoA-I chains in predominantly -helix secondary
structure and in anti-parallel orientation (Fig. 4B, right). The
open helical conformation of the two apoA-I molecules is
readily visualized in Fig. 4C, which provides a different vantage
point of the low resolution SANS shape (left), the high resolu-
tion protein in the double superhelix model (middle), and their
overlap (right). The relatively hydrophobic surface of apoA-I is
oriented inward, indicating the groove formed within the heli-
cal protein spiral abuts a central lipid core (Fig. 4D). In contrast,
FIGURE 3. Additional biological activities of nascent HDL. A, demonstra-
tion of anti-inflammatory activity of HDL preparations. The capacity of the
indicatedHDL preparations (or their individual components) to inhibit tumor
necrosis factor--induced enhanced VCAM-1 protein expression in HUVEC
cells was determined by cell-based ELISA as described under “Experimental
Procedures.” Note that both human HDL (pHDL) and reconstituted nascent
HDL containing purified human apoA-I from healthy donors (rHDL) prevent
VCAM-1 expression following tumor necrosis factor stimulation. B, demon-
stration of anti-apoptotic properties of HDL preparations. Apoptosis was
induced in HUVEC by 6 h of serum starvation. Cells were incubated simulta-
neously with pHDL, rHDL, apoA-I, or POPC, and the capacity of the indicated
HDL particle (or its components) to inhibit apoptosis was determined as
described under “Experimental Procedures.” Note that both the pHDL and
rHDL similarly protectHUVEC fromapoptosis.C, specific bindingofHDLprep-
arations to HDL receptor SR-BI. Binding was determined in SR-BI- and vector-
transfected 293-T cells by addition of iodinated rHDL. Specific binding was
calculated as described under “Experimental Procedures.” D, competition
binding assay of SR-BI. The capacity of the indicatedHDLpreparation to act as
a competitor and block SR-BI-specific binding of HDL isolated from plasma
was determined as described under “Experimental Procedures.” HDL isolated
from plasma was iodinated and used as ligand, and competition binding
studieswereperformedwith 30-fold excess nonlabeledplasmaHDL, the indi-
cated reconstituted HDL, including reconstituted HDL made from recombi-
nant human apoA-I (rrHDL), and small unilamellar vesicles (SUV) made of
POPC. SR-BI-specific binding of iodinated human HDL is considered 100%.
NA, no addition.
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the majority of hydrophilic amino
acids are oriented toward the outer
solvent-exposed surface (Fig. 4D). It
is worth noting that to accommo-
date theHD-MS/MS data the N ter-
mini of apoA-I are predicted to have
predominantly -helix secondary
structure as suggested previously
(64).
More quantitative analyses of the
goodness of fit of experimental
SANS andHD-MS/MS data and the
double superhelix model are shown
in both Table 1, and Fig. 4, E and F.
Calculated 
2 statistics that quantify
differences between the experimen-
tally determined and theoretical
scattering intensities show superior
fit for the double superhelix model
compared with belt and solar flares
models. Similarly, a close correla-
tion is observed between experi-
mental HD-MS/MS data and that
predicted for the double superhelix
model at both peptide (Fig. 4E) and
amino acid levels of resolution (Fig.
4F). The predicted conformation of
apoA-I in the double superhelix
model demonstrates substantially
improved fit with experimental HD-
MS/MS data, compared with that
predicted for apoA-I in the belt
model, and a similar fit of experi-
mentalHD-MS/MSdata in the solar
flares model (Fig. 4F and Table 1).
Lipid Core of Nascent HDL Is
Ellipsoidal—To visualize directly the
structure of the lipid core of nascent
HDL, we performed SANS at 42%
D2Ocontrast variation (Fig. 5A,black
dotted line). The HDL particles
studied this time were generated
with nondeuterated human apoA-I
isolated from plasma. At 42% D2O,
the solvent closelymatches the scat-
tering length density of the nondeu-
terated protein (match point 42%)
and to a lesser extent the lipid polar
head groups (match point 30%),
thus leaving mainly the acyl chains
(match point3%) of the lipid visi-
ble (58). The experimental radius of
gyration obtained for the lipid core
is 39.7 Å, which is about 10 Å
smaller than the radius of gyration
of the protein (51.3Å). These results
confirm that the protein compo-
nent of HDL is located predomi-
FIGURE 4.Superhelical structure of apoA-Iwithin nascentHDL revealedbySANSandHD-MS/MS.A, com-
parison of experimental SANS intensity from deuterated apoA-I-nascent HDL in 12% D2O buffer (black dotted
line) with calculated intensity of the double superhelixmodel (blue line), solar flaresmodel (green line), and belt
model (red line). B, SANS low resolution structure of apoA-I reconstructed from the experimentally obtained
scattering curve of nascent HDL (left) and the all-atom double superhelix model of apoA-I within nascent HDL
(right).C, 12%D2OSANS shape (black), apoA-I in thedouble superhelixmodel (red-blue), and their overlap from
a viewing angle that emphasizes the helical conformation of the protein; N termini are colored in dark red/blue
and C termini in light red/blue. D, map of “patch” hydrophobicity of apoA-I within nascent HDL in the double
superhelixmodel. Like thehydrophobic index, thepatchhydrophobicity is in the range [0,1] and is determined
for each amino acid residue by averaging the hydrophobic indices of neighboring residues (e.g. within 15 Å)
located on the same side of protein, i.e. either inside (facing lipid) or outside (facing solvent) (79). E, correlation
(R) between the experimentally measured deuterium incorporation factors (D0) for apoA-I peptic peptides
from nascent HDL versus the predicted (calculated) D0 values for both the belt (open circle) and double super-
helix (open triangle) models of nascent HDL. F, “goodness of fit” of the double superhelix, solar flares, and the
belt models at the individual residue level. The probability correction factor (PCF) plotted on the y axis repre-
sents the multiplier needed to adjust the exchange probability of individual residues within the model to
match that determinedby hydrogen/deuteriumexchangemass spectrometry studies. The dashed line at unity
represents the probability correction factor of a given amino acid within the model that possesses a confor-
mation with the same H/D exchange as observed by experimental measurement.
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nantly toward the outside of the particle, although the phos-
pholipid acyl chains occupy a more central location within the
HDL. The low resolution structure of the lipid core was initially
reconstructed from the experimental SANS data obtained from
nascentHDL solvatedwith 42%D2O (Fig. 5B and supplemental
Fig. S7). The overall structure of the HDL particle lipid core
visualized is clearly prolate ellipsoid. Next, we built a hypothet-
ical initial all-atommodel for the lipid of nascent HDL. As pro-
posed in earlier HDL models, the hydrophobic portion of the
lipids interacts with the hydrophobic surface of the protein, and
the lipid polar head groups are oriented toward the aqueous
phase.We thus used as scaffold for the initial model of the lipid
both the helical groove partially bounded by the hydrophobic
surface of the anti-parallel apoA-I chains and the overall ellip-
soidal structure of the lipid core visualized by SANS (supple-
mental Fig. S5 and S7 andTable S5).Hydrophobic acyl chains of
phospholipids were oriented toward the hydrophobic protein
surface (e.g. Fig. 4D) of the apoA-I helix. The initial model was
refined through iterative energyminimizations and evaluations
of the goodness of fit of SANS intensity for both protein and
lipid core shapes and amide proton solvent accessibility
throughout the entire polypeptide chain. In this manner, we
optimized the HDL structure such that minimal differences
between predicted versus experimental data (for both SANS
and HD-MS/MS) were achieved. Subsequently reported cross-
linking/mass spectrometry, fluorescence resonance energy
transfer, and electron spin resonance coupling distance con-
straints (20, 21, 48) were used as additional geometrical con-
straints for the overall shape of the protein within HDL, and
then a final energy minimization of the intact solvated particle
was performed (see supplemental Fig. S5, S6, and S7 and Table
S5). Molecular dynamics simulation was also performed (sup-
plemental Fig. S9) on the final computationalmodel, the double
superhelix model of nascent HDL, revealing a thermodynami-
cally stable particle that retained overall helical conformation of
apoA-I and preserved both the lipid organization and solvent-
exposed protruding apoA-I loops in the region previously iden-
tified as the LCAT-binding site inHDL (also known as the solar
flares (23)).
The structural model proposed for the lipid within the dou-
ble superhelix model of nascent HDL is shown in Fig. 5C. The
overall lipidmesophase is predicted to be predominantlymicel-
lar, while adopting a pseudolamellar arrangement in the vicin-
ity of the protein. It should be noted that if one assumes that the
packing arrangement of the lipid is essentially dictated by the
shape of the superhelical protein component of nascent HDL,
orienting the acyl chains toward the hydrophobic amphipathic
protein surface, an ellipsoidal lipid micelle is generated with
overall shape compatiblewith the low resolution structure visu-
alized for the lipid core of HDL (Fig. 5, B andC). Comparison of
the overall lipid shapes within various HDL models demon-
strates the structure posited for the double superhelix model is
more closely aligned with the experimental SANS scattering
data collected in 42% D2O (Fig. 5A). Furthermore, the calcu-
lated scattering intensity of lamellar mesophase (bilayer) lipids
for both belt and solar flares models are more skewed away
from the experimental SANS curve at lower scattering angles,
suggesting poorer fit with the experimental data (Fig. 5A). This
is confirmed by quantitative analysis of the goodness of fit of the
predicted scattering curves derived from the shape of the lipid
core of the double superhelixmodel versus both solar flares and
belt models, where significantly greater deviation from the
experimental SANS scattering data is observed with both the
solar flares and belt models, as indicated by the substantially
larger 
2 statistics (Table 1).
Global Dimensions of the Double Superhelix Model of Nas-
cent HDL—The overall dimensions of the experimentally de-
termined low resolution (SANS) structures for nascent HDL
and the double superhelix model are illustrated in Fig. 6, A–D.
Of note, the particle model is a prolate ellipsoid with global
proportions in close agreement with that observed by both
SANS and EM (Fig. 6, A–D, and Table 1). The anti-parallel
nature of the two apoA-I-helices are predicted to be stabilized
by multiple inter-chain salt bridges (Fig. 6C and supplemental
Table S7), providing structural support for the protein to serve
as a superhelical scaffolding upon which HDL lipids are trans-
ported. Individual particles in EM images correspond to pro-
jections of an ellipsoid of 55–65 Å in diameter and 160 Å in
TABLE 1
Goodness of fit of HDLmodels with experimental SANS, EM, and HD-MS/MS data
Radius of gyration, global dimensions, and goodness of fit of HDL models with experimental SANS, EM, and HD-MS/MS data are shown. Physical parameters, including
radius of gyration (Rg) and overall dimension of the double superhelix model of nascent HDL, are more consistent with the values measured both by SANS and small angle
x-ray scattering (SAXS) compared with the existing models of nascent HDL. Calculated 
2 statistics that quantify differences between the experimentally determined and
theoretical scattering intensities show superior fit for the double superhelix model compared with belt and solar flares models. More quantitative analysis of goodness of fit
of HDL models with HD-MS/MS data, including root mean square deviation (r.m.s.d.), probability correction factor (PCF), and correlation coefficient, suggest that the
double superhelix model fits better with the experimental data than the belt and solar flares models. l is length, w is width, and h is height.
Models Radius of gyration (Å) Dimensions (Å),l w h
2 a Correlation
coefficientb
r.m.s.d.c
HDL Protein Lipid Protein Lipid Peptide PCFd() PCF()
Experimental
SAXS 52.0 167
SANS 51.3 39.7 171 74 69
EM 160 60
Double superhelix 52.1 38.4 171 73 67 1.1 145 0.946 0.82 0.21 0.24
Solar flares 53.4 33.7 140 115 50 6.9 497 0.915 1.65 0.30 0.29
Belt 47.2 30.2 98 98 45 12.7 2,255 0.794 2.39 1.50 1.72
a
2 stands for the standard deviations between the experimental scattering data and calculated scattering data of nascent HDL models obtained from our modified SASSIM
Program54.
b Correlation coefficientwas correlation between theoretical hydrogen/deuteriumexchange probabilities of peptic peptides in themodel and the actual experimentallymeasured
deuterium incorporation within apoA-I peptic peptides.
c r.m.s.d. stands for root mean square deviation. It quantifies the difference between the experimental deuterium exchange data and the calculated ones.
d PCF stands for probability correction factor, which represents the multiplier needed to adjust theoretical deuterium incorporation of individual residues based upon the HDL
models to match that which was actually experimentally determined.
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length under different orientations. The internal structure of
the particles was not clearly discernable on EM, even after an
enhancement of the signal to noise ratio by classification, align-
ment, and averaging. Nonetheless, some class averages display
striations reminiscent of projections of the proposed double
superhelix model for HDL. Independent studies employing
small angle x-ray scattering yielded similar particle dimensions
(Table 1 and supplemental Fig. S8). The -helical content of
apoA-I within the double superhelix model as estimated by
PyMOL is 68%, similar to that observed by circular dichroism
measurements on the recombinant HDL particles (67%), and is
in close agreementwith values reported previously (65). Finally,
better than the earlier prominent HDL models reported in the
literature, all sequence-confirmed intra-chain and most inter-
chain distance constraints identified for apoA-I based upon
mass spectrometry analyses in
cross-linking studies (20, 48), fluo-
rescence resonance energy transfer
(21), or electron spin resonance
studies (21) are accommodated by
the superhelical conformation of
apoA-I in the double superhelix
model (Table 2 and supplemental
Fig. S4 and Table S6). An inter-
chain cross-link previously reported
(20, 48) that would be structurally
forbidden within a single HDL par-
ticle (Lys208–Lys208) could be
readily accommodatedbyacross-link
formed between a pair of particles
such as with rouleaux formation.
DISCUSSION
Biological Implications and Con-
text with Prior Studies—The model
of nascent HDL presented here is a
dramatic and surprising departure
from the entrenched view. The
open helical low resolution shape of
apoA-I visualized by SANS should
allow for a highly versatile particle
that can accommodate alterations
in shape and lipid composition dur-
ing particle maturation and remod-
eling, properties that undoubtedly
facilitate the ability of the particle to
support its transport function. The
superhelical conformation of apoA-I
helps to envision a path of HDL par-
ticle genesis from poorly lipidated
apoA-I through association of phos-
pholipid and sterol with a gradually
unfolding protein. Furthermore, the
free energy barrier for assembling
the lipid phase posited in the double
superhelix model should be less
than that required for construct-
ing a circumferentially enshrined
bilayer during HDL particle genesis such as required by discoi-
dal (i.e. belt and solar flares) models. Moreover, selective
uptake, exchange, or modification of lipids within HDL during
interaction with both its cell-based receptors or plasma en-
zymes will not generate an immediate asymmetric distribution
of lipids within the particle (i.e. a “heads” versus “tails” to the
disk), a problem intrinsic to all discoidal/bilayer-containing
models of HDL that to date has not been adequately addressed.
In contrast, lipids in the double superhelix model are free to
diffuse throughout the entire particle.
Nearly 3 decades ago, Atkinson et al. (66) reported the first
structural studies of HDL employing SANS with contrast vari-
ation. Although the detailed topography of protein and lipid
components remained undefined, the authors concluded that
the protein of HDL is located circumferentially relative to lipid
FIGURE 5. Prolate ellipsoid structure of the lipid core within nascent HDL revealed by SANS. A, com-
parison of experimental SANS intensity (black dotted line with error bars) at 42% D2O with the scattering
intensity of the double superhelix (blue line), solar flares (green line), and belt models (red line). B, low
resolution SANS structure of lipid core within nascent HDL reconstructed from the scattering intensity of
nascent HDL in 42% D2O solution. C, all-atom model of lipids in the double superhelix model of nascent
HDL illustrating both pseudo-lamellar and micellar organizational features. The phosphatidylcholine
headgroups are colored purple; the phospholipid acyl chains are green, and cholesterol is orange (left). The
prolate ellipsoid view (left) shows the pseudo-lamellar arrangement of lipids where the helical protein sits
(protein not shown; note the end-on-end orientation of the acyl chains within the grove where the apoA-I
has been removed). The cross-sectional view (right) illustrates the micellar-like packing of lipids. The two
apoA-I chains are shown as red and blue.
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within the particle and suggested a bilayer disk (oblate ellipsoid)
model for HDL. Additional studies on reconstituted HDL per-
formed by SAXS without contrast variation and molecular
dynamics simulations (67, 68) either lent support to the idea of
HDL being discoidal or did not define a low resolutionmodel of
nascent HDL with contrast variation. In preliminary SANS
studies, we similarly could not define the low resolution shape
of apoA-IwithinHDLbecause of both aweak protein signal and
the overlap between the scattering signal from protein and
phospholipid at higher angles. The use of deuterated apoA-I for
nascent HDL generation proved key in permitting direct visu-
alization of the open helical conformation of the protein within
theHDL particle.Moreover, the helical architecture of the pro-
tein within HDL suggests a predominantly micellar and pseu-
do-lamellar organization of the lipids within the prolate ellip-
soidal shape visualized by SANS for the lipid core of nascent
HDL. It is of interest thatWeisgraber and co-workers (69) used
small angle x-ray scattering to explore the structure of apoli-
poprotein E-dipalmitoyl phosphatidylcholine particles in solu-
tion and observed a “quasi-spheroidal” particle with hairpin-
containing apolipoprotein E and an
ellipsoidal shaped lipid core with
posited phospholipid packing simi-
lar to a micelle, which they termed
the “twisted bilayer” model.
Prior computational modeling
for nascent HDL has suggested a
discoidal particle composed of a
double belt conformation of
apoA-I encircling a lipid bilayer
(18). This was based upon studies
of particles with alternative com-
position (e.g. 80:1, mol/mol,
PC:apoA-I) and with an N-termi-
nal (
43) truncated apoA-I, the ini-
tial form of lipid-free apoA-I crys-
tallized (70). The HDL particle
composition selected for this study,
themethods for particle generation,
and the detailed functional charac-
terizations performed demonstrate
a biologically active particle similar
in composition to nascent HDL (96
Å form) generated by macrophages
(31). Moreover, the reconstituted
HDL preparations examined have
similar composition to those used in
many recent HDL-based human
therapeutic intervention trials (9,
28, 30, 71, 72). Although the present
study focuses solely on a single
reconstituted HDL form similar in
composition and biological activi-
ties to nascent HDL, we cannot
exclude the possibility that HDL
particles composed of different pro-
tein/lipid compositions and alterna-
tive apolipoprotein polypeptide
chain lengths may assume different global architecture and
lipid organization. The lipid structural studies performed do
not directly visualize the detailed packing arrangement of the
lipid of HDL and thus do not exclude the possibility of an alter-
native organization.
The computational model of nascent HDL (the double super-
helixmodel) was obtained by combining the low resolution struc-
tures obtained by SANS with contrast variation and selective
deuteration of apoA-I and data from multiple experimental
studies of HDL using novel integrative computational methods
(e.g. HD-MS/MS, cross-linking/mass spectrometry, fluores-
cence resonance energy transfer, and electron spin resonance
coupling). Interestingly, although no crystal structures of lipid-
free apoA-I were used (other than the incorporation of an anti-
parallel orientation of apoA-I chains as originally suggested by
the lipid free
43-N-terminal truncated apoA-Imutant (70)), it
is remarkable to note that the conformation of apoA-I in the
double superhelix model contains several turns found in the
recently reported crystal structure of lipid-free full-length
apoA-I (Protein Data Bank code 2A01) (73). As Fig. 7A shows,
FIGURE 6. Geometrical dimensions and electron microscopy imaging of nascent HDL. A, overlay of the
SANS low resolution structures of apoA-I (light blue) and lipid core (green) within nascent HDL. The lipid core
structure shows clear invaginations that are approximately filled by protein. B, overlay of apoA-I and lipid
all-atom double superhelix model of nascent HDL. The superhelical shape of the protein is emphasized by the
semi-transparent representation of the lipid core, inwhich phospholipid is depicted in green and cholesterol in
orange. C, illustration of the anti-parallel amino acid arrangement proposed in the double superhelixmodel of
apoA-I in nascent HDL. The two apoA-I molecules are aligned in a head to tail anti-parallel arrangement using
ahelix 5/helix 5 registry (yellow). TheN termini are coloredwithdark red/blue, and theC termini are coloredwith
light red/blue. Twenty eight inter-chain salt bridges that stabilize the anti-parallel double superhelical confor-
mation of apoA-I are also illustrated as sticks. D, characteristic negative stain electron microscopic image of
nascent HDL, along with two expanded views of the indicated insets. The scale bar corresponds to 15 nm.
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there are five turning loops in the reported crystal structure
of lipid-free apoA-I (Protein Data Bank 2A01) that start with
leucine and most of them end with leucine (Leu38–Leu47,
Leu82–Ala95, Leu137–Leu144, Leu189–Ala196, and Leu214–
Leu218). Three of these turns (Leu38–Leu47, Leu82–Ala95,
and Leu214–Leu218) are also present as turns in the double super-
helix model of apoA-I (Fig. 7B). Interestingly, a bend is also
observed in both chains of apoA-I of the double superhelix
model at the remaining two turns of lipid-free apoA-I (Fig. 7B).
Moreover, one of these turns (Fig. 7B, turn 3) partially forms
following molecular dynamics simulation of the double super-
helix model (supplemental Fig. S9) and corresponds to a region
on apoA-I suggested by Oda and co-workers (21) to adopt a
hairpin loop structure. These studies relied upon multiple
site-specific mutated forms of apoA-I combined with deri-
vatization with detector molecules (e.g. spin adducts or bulky
aromatic species). Although one of the inter-chain distance
constraints observed (e.g. position 133 on each chain) is
readily satisfied in the double superhelix model (Table 2),
another one (position 146 on each chain) is not (Table 2). By
changing the registry of the two apoA-I chains, this inter-
chain distance constraint can be accommodated; however,
this also results in a structure that no longer satisfies some of
the reported cross-links (supplemental Fig. S4). It should
also be noted that introduction of a loop within the helix 5
region of apoA-I of the double superhelix model causes the
following to occur: (i) reduces the agreement of the pre-
dicted SANS scattering curve with the experimental SANS
data; (ii) deteriorates the goodness of fit between experimen-
tal and theoretical HD-MS/MS deuterium incorporation
factors for this region; and (iii) renders some of the reported
cross-links forbidden regardless of whether the loop is intro-
duced into the double superhelix or belt models of apoA-I
(supplemental Fig. S4). In contrast to studies with SANS and
HD-MS/MS, which are nonperturbing, studies that employ
mutations of apoA-I, while informative, need to be inter-
preted within the context of recognizing that structural and
functional alterations to the particle may be introduced. For
example, HDL particles generated with recombinant mutant
apoA-I that lack all four of the endogenous tryptophan res-
idues, the mutant form of apoA-I often used as a backbone
for additional site-specific mutants studied by fluorescence
resonance energy transfer and electron spin resonance, can
have markedly impaired cholesterol efflux function depend-
ing upon the amino acid used to replace the tryptophan (74).
Our present studies do not rule out the possible formation of
transient loop structures anywhere throughout the apoA-I
polypeptide because the overall shape of the proposed dou-
ble superhelix model arises from the overall time-averaged
conformation of apoA-I within the ensemble of various nas-
cent HDL conformations in solution visualized by SANS.
Indeed, the double superhelix model readily accommodates
a highly dynamic conformation of apoA-I while retaining
lipid binding properties within the particle. Although the
precise location of small structural elements along the
apoA-I chain of nascent HDL may still be debated, the stud-
ies reported here suggest that the overall time-averaged glo-
bal architecture of apoA-I within nascent HDL (at least for
the studied lipid/protein composition) is an open spiral (Fig.
7, C and D).
Another remarkable feature of the double superhelix
model of nascent HDL is that numerous previously reported
structural constraints (inter-chain distances based upon
cross-linking/mass spectrometry, fluorescence resonance
energy transfer, and electron spin resonance studies) used to
argue in favor of prior models can be readily accommodated
within the observed open helical conformation of apoA-I
(Table 2 and supplemental Table S6). Moreover, some
regional structural features proposed in prior studies that
were not easily accommodated by the closed belt structures
can be more readily accommodated within the open and
dynamic apoA-I helical conformation. For example, Thomas
and co-workers (20) reported that the N terminus of apoA-I
folds back upon the apoA-I chain allowing for detection of a
cross-link between inter-chain residues Lys12 and Lys182.
Another intra-chain cross-link between Lys94 and the
apoA-I chain N terminus was similarly reported by Davidson
and co-workers (48). The double superhelix model accom-
modates the cross-link between Lys12 and Lys182 (Table 2).
Furthermore, small changes in the conformation of the
N-terminal region of apoA-I readily bring the N terminus
and Lys94 within permissible distance for cross-linking (sup-
plemental Fig. S10).
TABLE 2
Goodness of fit of HDLmodels with experimental SANS, EM, and
HD-MS/MS data
Amino acid distance constraints between  and  chains of apoA-I within nascent
HDL obtained from fluorescence resonance energy transfer (FRET), HPLC tandem
mass spectrometry (MS/MS), and electron spin resonance coupling (ESR) are
shown.
Residues Double helix model Methods
Å
Trp50–Leu230 22.8a FRET (22.7 Å)b
Trp72–Ala210 30.2 FRET (23.5 Å)a
Leu90–Ala190 26.2 FRET (24.0 Å)a
Trp108–Leu170 26.6 FRET (28.8 Å)a
Gln132–Gln132 17.3c FRET (30–35 Å)a
Lys40–Lys239 30.1d MS/MS (12 Å)e,f,g
Lys118–Lys140 10.7 MS/MS (12 Å)e,f,g
Lys12–Lys182 16.1 MS/MS (12 Å)e,g
Lys59–Lys208 15.6 MS/MS (12 Å)f
Lys77–Lys195 18.1 MS/MS (12 Å)f
Lys133–Lys140 6.4 MS/MS (7.7 Å)g
Lys208–Lys208 h 160.1 MS/MS (12 Å)f
Lys88–Lys118 h 69.1 MS/MS (12 Å)f
Lys96–Lys118 h 64.2 MS/MS (12 Å)f
Lys133–Lys133 i 6.2 ESR (15 Å)a
Glu146–Glu146 i 43.8 ESR (15 Å)a
Leu134–Leu134 i 10.9 ESR (17–19 Å)a
a The calculated distances between two residues in the double superhelix model of
nascent HDL are from the far end of the side chain of Trp to the far end of
N-acetylaminoethyl-1-aminonaphthalene sulfonate acceptor assuming free rota-
tion of the side chain of amino acids.
b Data are fromMartin et al. (21).
c Data are from Li et al. (80).
d The calculated distances in the double superhelix model of nascent HDL are
between -amine groups of two lysines assuming free rotation of the side chain of
lysines.
e Data are from Bhat et al. (20).
f Data are from Silva et al. (48).
g Data are from Bhat et al. (81).
h Data are not compatible with 5/5 registry.
i The calculated distances between two residues in the double superhelix model of
nascent HDL are from the oxygen atom of methane thiosulfonate nitroxide spin
label on one residue to the oxygen atom of methane thiosulfonate nitroxide spin
label of the other residue.
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A structural feature predicted in the double superhelix
model is the presence of two highly dynamic and solvated
apoA-I loops previously identified to support LCAT docking
and activation within nascent HDL, also known as the so-called
solar flares (23).Molecular simulation studies performedon the
double superhelix model (supplemental Fig. S9) support the
dynamic character and solvent accessibility of apoA-I in this
region and show that the “solar flares” remain highly solvent-
exposed over prolonged simulation
time (4 ns), with breaking and re-
formation of salt bridges. This con-
trasts with a recently reported
molecular dynamics simulation that
claims that the solar flares “col-
lapse” in the solar flares model
because disruption of one or more
predicted salt bridge as visualized in
a single time frame of a brief (1 ns)
simulation (75). Because no His
in their model were protonated, the
model they used for simulation dif-
fers from that employed in our past
and present studies, as well as in
other computational studies (e.g.
the belt model (18)). As illustrated
in Fig. 8, the experimentally mea-
sured deuterium incorporation fac-
tors for residues within the peptide
corresponding to the solar flare loop
(e.g. Arg160B–Arg177B) show a high
degree of deuterium incorporation
(average D0i  0.8). This is because
the residues within this region of
apoA-I are very dynamic (derived
average per residue unfolding equi-
librium constant, Kui 102), and
their amide hydrogens exchange
rapidly (derived average per residue
exchange rate constant, kxci 0.23
s1), regardless of whether they are
involved in H-bonding or not (see
supplemental Table S3). In contrast,
the amide hydrogens of the residues
in the adjacent -helix from the
anti-parallel apoA-I chain (Lys77A–
Lys106A), by comparison, show
reduced deuterium incorporation
(average D0i  0.47), are substan-
tially less dynamic (Ku 103), and
their amide hydrogens exchange an
order of magnitude slower (kxc
2.67 102 s1) (Fig. 8).
Lipoproteins participate in
numerous biological functions,
including sterol and lipid trans-
port, organismal energy metabo-
lism, and innate immunity.
Despite their central role in multi-
ple pathophysiologically relevant processes, as a class, intact
lipidated lipoproteins have defied high resolution structural
characterization because of their heterogeneous composi-
tion, dynamic/polymorphic nature, and large size. This lack
of structural definition hinders fundamental understanding
of pathobiological processes and potential development of
therapeutic interventions. By uniting the complementary
and nonperturbing approaches of SANS and HD-MS/MS in
FIGURE 7. Double superhelix model of nascent HDL. A and B, illustration that apoA-I within nascent HDL
retains structural features of full-length lipid-free apoA-I. A, crystal structure of lipid-free apoA-I (73) with
residues in the turning loops colored in yellow: Leu38–Leu47 (turn 1); Leu82–Ala95 (turn 2); Leu137–Leu144 (turn 3);
Leu189–Ala196 (turn 4); and Leu214–Leu218 (turn 5). B, turns in lipid-free apoA-I mapped onto the double super-
helix model of apoA-I. Turns in lipid-free apoA-I that no longer correspond to turns within the double super-
helixmodel are colored in cyan.Turns 1, 2, and5 from lipid-free apoA-I are alsopresent in thedouble superhelix
model.C, locationsof theLCAT interaction site (residues159–170, yellow) andmyeloperoxidase (MPO)-binding
site (residues 190–203, light blue) in the double superhelix model of apoA-I. Two residues, Tyr166 and Tyr192,
which undergo site-specific oxidative modifications within human atherosclerotic lesions, are shown in black.
D, all-atom double superhelix model of nascent HDL with known protein-protein interaction sites; POPC
(green) and cholesterol (orange) are viewed in semitransparent mode. The dashed line shown represents the
hypothetical overlay of a discoidal model of HDL, showing overall similar size.
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combination with computational and bioinformatic meth-
ods, we have applied a multidisciplinary and broadly appli-
cable methodology for the structural study of solution phase
macromolecular complexes resistant to traditional high res-
olution structural interrogation, such as lipoproteins. Appli-
cation of this approach revealed a totally unexpected confor-
mation of apoA-I in the nascent HDL particle, a double
superhelix. Overall, the protein seems to play the role of a
backbone giving mechanical strength to the HDL particle,
while acting as an interface for both lipid binding/transport
and specific interactions with plasma enzymes and cell
receptors. The observed open helical shape of apoA-I, lipid
arrangement, and overall ellipsoidal particle shape accounts
for geometrical, biophysical, and biochemical data reported
to date. It also has not escaped our attention that a helical
shape for a protein scaffolding for a lipoprotein envisages a
credible generalized pathway for lipoprotein biogenesis,
maturation, and remodeling.
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